Form4insider filings, from the source

Insider · CIK 0001469547

Vivo Ventures VI, LLC

Files at: SGNT, EIGR, KALV. On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $8.1M · 2sales $11.0M · 3net −$3.0M
$10k$10k$1M$1M$100M$100MbuyssalesApr 2015Jul 2015Sep 2015Dec 2015Mar 2016May 2016Aug 2016

Reported trades — common stock

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Aug 18, 2016 PForm 4 →Aug 22, 1:43 pm EDTEiger BioPharmaceuticals, Inc.EIGR187,500$16.00$3,000,00012,996— plan?
Apr 21, 2016 SForm 4 →Sep 1, 6:01 pm EDTSagent Pharmaceuticals, Inc.SGNT2,316$13.55$31,38225,320−8.38% plan? late
Apr 21, 2016 SForm 4 →Apr 25, 4:37 pm EDTSagent Pharmaceuticals, Inc.SGNT2,316$13.55$31,38225,320−8.38% plan?
Nov 2, 2015 SForm 4 →Nov 4, 6:36 pm ESTSagent Pharmaceuticals, Inc.SGNT696,823$15.72$10,957,20725,337−96.5% plan?
Apr 14, 2015 PForm 4/A →Apr 24, 7:03 pm EDTCarbylan Therapeutics, Inc.CBYL1,012,500$5.00$5,062,5004,204,562+31.7% plan?
Apr 14, 2015 CForm 4/A →Apr 24, 7:03 pm EDTCarbylan Therapeutics, Inc.CBYL3,192,062——3,192,062— plan?
Apr 14, 2015 PForm 4 →Apr 14, 5:19 pm EDTCarbylan Therapeutics, Inc.CBYL1,012,500$5.00$5,062,5004,204,564+31.7% plan? amended
Apr 14, 2015 CForm 4 →Apr 14, 5:19 pm EDTCarbylan Therapeutics, Inc.CBYL3,192,064——3,192,064— plan? amended

Reported trades — derivatives (options, RSUs, warrants)

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Apr 14, 2015 CForm 4/A →Apr 24, 7:03 pm EDTCarbylan Therapeutics, Inc.CBYL3,192,062——0—
Apr 14, 2015 CForm 4 →Apr 14, 5:19 pm EDTCarbylan Therapeutics, Inc.CBYL3,192,064——0— amended